Last updated: 2026-06-11
THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN ACCESS THIS INFORMATION. PLEASE REVIEW IT CAREFULLY.
This Notice of Privacy Practices ("Notice") describes privacy practices for Protected Health Information ("PHI") maintained in connection with services made available through Avono LLC, operating the Avono Health brand, and independent licensed Providers, professional entities, pharmacies, laboratories, and other Clinical Partners to the extent they are subject to HIPAA or use Avono-related administrative services. Independent Providers, pharmacies, laboratories, and other Clinical Partners may provide separate notices that also apply to their services.
To the extent HIPAA applies, we and applicable covered Providers are required by law to maintain the privacy and security of PHI, provide this Notice, follow the duties and privacy practices described in the current Notice, and notify affected individuals following a breach of unsecured PHI when required by law.
We reserve the right to change this Notice and make the revised Notice effective for PHI we already have as well as PHI we receive in the future. The current Notice will be made available through the Services or upon request.
When HIPAA applies to your PHI, you have the following rights, subject to legal limits:
To exercise a right or file a privacy complaint with Avono, contact compliance@avono.io. You may also file a complaint with the U.S. Department of Health and Human Services, Office for Civil Rights. We will not retaliate against you for filing a complaint.
We may use and disclose PHI for treatment, payment, and health care operations without your written authorization as permitted by HIPAA.
We may use or disclose PHI without your authorization when permitted or required by law, including for the following purposes:
Except where permitted by law, we will obtain your written authorization before using or disclosing PHI for marketing communications that require authorization, selling PHI, or using or disclosing psychotherapy notes if any are maintained. Other uses and disclosures not described in this Notice will be made only with your authorization where required by law.
We may contact you about appointments, reminders, intake items, lab requests, prescription coordination, refills, support, treatment alternatives, health-related benefits, services that may interest you, and care coordination. Communications may occur by portal, email, phone, SMS/text, mail, or other methods consistent with your consents and applicable law.
We may disclose PHI to a family member, friend, caregiver, personal representative, or other person involved in your care or payment for your care if you agree, do not object when given the opportunity, or if we reasonably infer based on professional judgment that the disclosure is in your best interest and permitted by law.
Certain information, including substance use disorder treatment records subject to 42 CFR Part 2, genetic information, HIV/AIDS information, mental health information, reproductive or sexual health information, and other sensitive categories, may receive additional protections under federal or state law. To the extent we maintain such information, we will use and disclose it only as permitted by applicable law and any required consent or authorization.
When using, disclosing, or requesting PHI, we will make reasonable efforts to limit PHI to the minimum necessary to accomplish the intended purpose, except where the minimum necessary standard does not apply, such as disclosures for treatment or disclosures authorized by you.
If a breach of unsecured PHI occurs, we will notify affected individuals and others as required by applicable law.
For questions about this Notice, privacy rights, or complaints, contact Avono at compliance@avono.io.
Avono Health
compliance@avono.io
avonohealth.com